Announced Wed, 30 Sept, 2026 · 15:11 IST

Board approves related party deal with GSK Enterprises

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
—Next day
₹175.00
prior close
—
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.5%—
Restaurants peers, median of 12sector-0.6%—
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
—-0.3—-0.8—
Next day
—-1.5—-0.6—
2d
—-1.5—-1.0—
3d
—-0.2—+0.6—
4d
-4.3-0.5-3.8+0.3-4.6
5d
-7.4-3.2-4.2-2.7-4.7
1w
—-2.2—-3.5—
15d
—-9.5—-10.8—
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Restaurants peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

PECOS Hotels and Pubs board met on 30 September 2026 at the Bangalore corporate office from 2:00 PM to 3:00 PM IST. The board considered and approved a related party transaction between the company and GSK Enterprises Private Limited. The company has not disclosed the value or terms of the deal. The disclosure was filed under SEBI LODR Regulation 30, 2015. PECOS is listed on the BSE SME platform under security code 539273.

Likely market impact

Related party deals carry potential conflict of interest risk. Investors should monitor for further disclosures on deal size and terms.